121 related articles for article (PubMed ID: 10328987)
1. Animal models of CRH deficiency.
Venihaki M; Majzoub JA
Front Neuroendocrinol; 1999 Apr; 20(2):122-45. PubMed ID: 10328987
[TBL] [Abstract][Full Text] [Related]
2. Lessons from CRH knockout mice.
Venihaki M; Majzoub J
Neuropeptides; 2002; 36(2-3):96-102. PubMed ID: 12359501
[TBL] [Abstract][Full Text] [Related]
3. Corticotropin-releasing hormone deficiency reveals major fetal but not adult glucocorticoid need.
Muglia L; Jacobson L; Dikkes P; Majzoub JA
Nature; 1995 Feb; 373(6513):427-32. PubMed ID: 7830793
[TBL] [Abstract][Full Text] [Related]
4. Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.
Bale TL; Contarino A; Smith GW; Chan R; Gold LH; Sawchenko PE; Koob GF; Vale WW; Lee KF
Nat Genet; 2000 Apr; 24(4):410-4. PubMed ID: 10742108
[TBL] [Abstract][Full Text] [Related]
5. Effects of acute "binge" cocaine on preprodynorphin, preproenkephalin, proopiomelanocortin, and corticotropin-releasing hormone receptor mRNA levels in the striatum and hypothalamic-pituitary-adrenal axis of mu-opioid receptor knockout mice.
Zhou Y; Spangler R; Schlussman SD; Yuferov VP; Sora I; Ho A; Uhl GR; Kreek MJ
Synapse; 2002 Sep; 45(4):220-9. PubMed ID: 12125043
[TBL] [Abstract][Full Text] [Related]
6. Differential disinhibition of the neonatal hypothalamic- pituitary-adrenal axis in brain-specific CRH receptor 1-knockout mice.
Schmidt MV; Deussing JM; Oitzl MS; Ohl F; Levine S; Wurst W; Holsboer F; Müller MB; de Kloet ER
Eur J Neurosci; 2006 Oct; 24(8):2291-8. PubMed ID: 17042789
[TBL] [Abstract][Full Text] [Related]
7. The role of corticotropin-releasing hormone in immune-mediated cutaneous inflammatory disease.
O'Kane M; Murphy EP; Kirby B
Exp Dermatol; 2006 Mar; 15(3):143-53. PubMed ID: 16480421
[TBL] [Abstract][Full Text] [Related]
8. The corticotropin-releasing hormone network and the hypothalamic-pituitary-adrenal axis: molecular and cellular mechanisms involved.
Bonfiglio JJ; Inda C; Refojo D; Holsboer F; Arzt E; Silberstein S
Neuroendocrinology; 2011; 94(1):12-20. PubMed ID: 21576930
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling identifies the CRH/CRH-R1 system as a modulator of neurovascular gene activity.
Deussing JM; Kühne C; Pütz B; Panhuysen M; Breu J; Stenzel-Poore MP; Holsboer F; Wurst W
J Cereb Blood Flow Metab; 2007 Aug; 27(8):1476-95. PubMed ID: 17293846
[TBL] [Abstract][Full Text] [Related]
10. Corticotropin-releasing hormone, stress and human reproduction: an update.
Kalantaridou SN; Zoumakis E; Makrigiannakis A; Lavasidis LG; Vrekoussis T; Chrousos GP
J Reprod Immunol; 2010 May; 85(1):33-9. PubMed ID: 20412987
[TBL] [Abstract][Full Text] [Related]
11. The hypothalamic-pituitary-adrenal and the hypothalamic- pituitary-gonadal axes interplay.
Mastorakos G; Pavlatou MG; Mizamtsidi M
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():172-81. PubMed ID: 16641855
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone and urocortin: redundant or distinctive functions?
Gysling K; Forray MI; Haeger P; Daza C; Rojas R
Brain Res Brain Res Rev; 2004 Dec; 47(1-3):116-25. PubMed ID: 15572167
[TBL] [Abstract][Full Text] [Related]
13. Expression of type 1 corticotropin-releasing hormone (CRH) receptor mRNA in the hypothalamic paraventricular nucleus following restraint stress in CRH-deficient mice.
Makino S; Tanaka Y; Nazarloo HP; Noguchi T; Nishimura K; Hashimoto K
Brain Res; 2005 Jun; 1048(1-2):131-7. PubMed ID: 15919058
[TBL] [Abstract][Full Text] [Related]
14. The hypothalamo-pituitary axis responses to lipopolysaccharide-induced endotoxemia in mice lacking inducible nitric oxide synthase.
Akasaka S; Nomura M; Nishii H; Fujimoto N; Ueta Y; Tsutsui M; Shimokawa H; Yanagihara N; Matsumoto T
Brain Res; 2006 May; 1089(1):1-9. PubMed ID: 16631135
[TBL] [Abstract][Full Text] [Related]
15. Corticotropin-releasing hormone regulates IL-6 expression during inflammation.
Venihaki M; Dikkes P; Carrigan A; Karalis KP
J Clin Invest; 2001 Oct; 108(8):1159-66. PubMed ID: 11602623
[TBL] [Abstract][Full Text] [Related]
16. The stress system in the human brain in depression and neurodegeneration.
Swaab DF; Bao AM; Lucassen PJ
Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
[TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenocortical system and mood disorders: highlights from mutant mice.
Müller MB; Uhr M; Holsboer F; Keck ME
Neuroendocrinology; 2004 Jan; 79(1):1-12. PubMed ID: 14755129
[TBL] [Abstract][Full Text] [Related]
18. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor.
Bhatnagar S; Sun LM; Raber J; Maren S; Julius D; Dallman MF
Physiol Behav; 2004 Jun; 81(4):545-55. PubMed ID: 15178147
[TBL] [Abstract][Full Text] [Related]
19. Effects of corticotropin-releasing hormone (CRH) on the synthesis and secretion of proopiomelanocortin-related peptides in the anterior pituitary: a study using CRH-deficient mice.
Fukuda Y; Kageyama K; Nigawara T; Kasagi Y; Suda T
Neurosci Lett; 2004 Sep; 367(2):201-4. PubMed ID: 15331153
[TBL] [Abstract][Full Text] [Related]
20. Intracerebroventricular administration of corticotrophin-releasing hormone receptor antagonists produces different effects on hypothalamic pituitary adrenal responses to novel restraint depending on the stress history of the animal.
Vining C; Iyer V; Bhatnagar S
J Neuroendocrinol; 2007 Mar; 19(3):198-207. PubMed ID: 17280593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
